Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/9469
Title: | Effect of mud compress therapy on cartilage destruction detected by CTX-II in patients with knee osteoarthritis | Authors: | Gungen, G.O. Ardıç, Füsun Fındıkoğlu,Gülin Rota, Simin |
Keywords: | balneotherapy Biomarker bone CTX-II spa subchondral carboxy terminal telopeptide collagen type 2 biological marker C-terminal cross-linking telopeptide of type II collagen, human peptide fragment adult aged Article body mass cartilage degeneration comparative effectiveness compression therapy conservative treatment disease severity female follow up hot pack therapy human knee osteoarthritis knee pain major clinical study male mud compress therapy pain assessment pain intensity physical activity postmenopause priority journal visual analog scale articular cartilage comparative study knee middle aged mud therapy Osteoarthritis, Knee pathophysiology urine Aged Biomarkers Cartilage, Articular Collagen Type II Female Humans Knee Joint Male Middle Aged Mud Therapy Peptide Fragments Visual Analog Scale |
Publisher: | IOS Press | Abstract: | BACKGROUND/OBJECTIVE: The aim of this study is to investigate the effect of mud compress (MC) therapy compared to hot pack (HP) therapy on cartilage destruction and subchondral bone alterations detected by urine levels of C telopeptide fragment of collagen type-II (uCTX-II) in patients with knee osteoarthritis (OA). METHODS: Fifty-nine patients between 49-74 years of age with bilateral knee OA divided into 2 groups. Twenty-five patients (16 females, 9 males) and 34 patients (22 females, 13 males) were given HP versus local natural organic and mineral-rich MC therapy respectively for 2 weeks as a total of 12 sessions. uCTX-II, Visual Analog Scale (VAS), 15 m walking time, Western Ontario and McMaster Universities multifunctional (WOMAC) index were measured at baseline, after-treatment and 3 months after treatment. RESULTS: uCTX-II level did not show any difference between the two groups, however it decreased significantly in MC and HP groups 3 months after treatment (p< 0.017). WOMAC stiffness sore was significantly lower in MC group 3 months after treatment (p< 0.05). Both MC and HP therapies lowered VAS, WOMAC total and subscores significantly up to 3 months (p< 0.017). CONCLUSIONS: HP and MC therapies for OA of knee are not superior to one another with respect to the level of uCTX-II. MC may probably decrease the ongoing cartilage destruction and related subchonral bone interactions earlier compared to HP treatment in patients with knee OA as evidenced by decreased uCTX-II levels after-treatment. © 2016 IOS Press and the authors. | URI: | https://hdl.handle.net/11499/9469 https://doi.org/10.3233/BMR-150629 |
ISSN: | 1053-8127 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
SCOPUSTM
Citations
13
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
11
checked on Nov 14, 2024
Page view(s)
76
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.